Not Authorized
You are currently not authorized to access this section.
Please contact your Administrator to change your authorization settings.
Please contact your Administrator to change your authorization settings.
Company Overview
Accelovance is an award winning, clinical development Contract Research Organization (CRO) focused on vaccine, oncology, and general medicine Phase I-IV programs. Providing global full CRO services to pharmaceutical companies, biotechs, CROs, and academic institutions; Accelovance supports client needs by leveraging operational knowledge and patient recruitment strategies that result in successful clinical trials.
Accelovance owns and operates a Clinical Call Center that assists in recruitment, retention, and surveillance. This knowledge, applied externally to sites and coupled with the therapeutic talent and experience of our team members, creates predictable, controlled enrollment and retention of quality patients ensuring study success.
Unique in comparison to most CROs, Accelovance provides complete clinical trial understanding and expertise by leveraging knowledge gained from our investigative site network subsidiary, Optimal Research, a US site management organization. The network includes wholly-owned research centers and a network of pediatric and oncology-focused clinical sites, enabling Optimal to conduct pediatric and oncology research as well as healthy volunteer and general population studies. These sites are structured for productivity – combining proven patient recruitment efforts with properly resourced staff and engaged/experienced Principal Investigators.
Accelovance has been named Vaccine Industry Excellence’s (ViE) Best CRO in 2009, 2010, and 2011; and received a “Highly Recommended” distinction in 2013. This external validation of Accelovance’s vaccine research experience and success is a result of our ability to guarantee budgets, control timelines, and accelerate patient enrollment – delivering business solutions that address our clients’ clinical needs.
Established in 2005 with a corporate mission to improve the quality and predictability in clinical research, Accelovance has made significant strides in the industry by combining strong business and operational perspective with clinical and medical expertise.
Accelovance owns and operates a Clinical Call Center that assists in recruitment, retention, and surveillance. This knowledge, applied externally to sites and coupled with the therapeutic talent and experience of our team members, creates predictable, controlled enrollment and retention of quality patients ensuring study success.
Unique in comparison to most CROs, Accelovance provides complete clinical trial understanding and expertise by leveraging knowledge gained from our investigative site network subsidiary, Optimal Research, a US site management organization. The network includes wholly-owned research centers and a network of pediatric and oncology-focused clinical sites, enabling Optimal to conduct pediatric and oncology research as well as healthy volunteer and general population studies. These sites are structured for productivity – combining proven patient recruitment efforts with properly resourced staff and engaged/experienced Principal Investigators.
Accelovance has been named Vaccine Industry Excellence’s (ViE) Best CRO in 2009, 2010, and 2011; and received a “Highly Recommended” distinction in 2013. This external validation of Accelovance’s vaccine research experience and success is a result of our ability to guarantee budgets, control timelines, and accelerate patient enrollment – delivering business solutions that address our clients’ clinical needs.
Established in 2005 with a corporate mission to improve the quality and predictability in clinical research, Accelovance has made significant strides in the industry by combining strong business and operational perspective with clinical and medical expertise.
Company Summary
Name
Accelovance
Number of Employees
100-499
Website
Phone
(240) 238-4900